BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10549101)

  • 1. [Does symptomatic gastroesophageal reflux present a risk factor for development of adenocarcinoma of the esophagus?].
    Kellner H; Zoller WG
    Z Gastroenterol; 1999 Oct; 37(10):1071-3. PubMed ID: 10549101
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is there an endobrachy-esophagus cancer sequence?].
    Hameeteman W; Tytgat GN
    Internist (Berl); 1990 Feb; 31(2):119-23. PubMed ID: 2180839
    [No Abstract]   [Full Text] [Related]  

  • 3. [Topic Complex VI: Barrett esophagus].
    Messmann H; Ell C; Fein M; Kiesslich R; Ortner M; Porschen R; Stolte M
    Z Gastroenterol; 2005 Feb; 43(2):184-90. PubMed ID: 15700212
    [No Abstract]   [Full Text] [Related]  

  • 4. [Topic complex I: Definitions, epidemiology and natural course].
    Schepp W; Allescher HD; Frieling T; Katschinski M; Malfertheiner P; Pehl C; Peitz U; Rösch W; Hotz J
    Z Gastroenterol; 2005 Feb; 43(2):165-8. PubMed ID: 15700207
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastroesophageal reflux disease and Barrett's esophagus.
    Anand O; Wani S; Sharma P
    Endoscopy; 2008 Feb; 40(2):126-30. PubMed ID: 18058620
    [No Abstract]   [Full Text] [Related]  

  • 6. From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.
    Wang RH
    World J Gastroenterol; 2015 May; 21(17):5210-9. PubMed ID: 25954094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [No grounds for Barrett hysteria. Current monitoring strategies are adequately reliable].
    Schilling D; Riemann JF
    MMW Fortschr Med; 2002 Jul; 144(27-28):40-1. PubMed ID: 12198878
    [No Abstract]   [Full Text] [Related]  

  • 8. Total endoscopic eradication of Barrett's esophagus: study methodology, candidate selection, and clinical outcomes.
    Shaheen NJ; Spechler SJ
    Endoscopy; 2008 Dec; 40(12):994-9. PubMed ID: 19065482
    [No Abstract]   [Full Text] [Related]  

  • 9. [Markers of malignant potential and clinical management of dysplasia in Barrett esophagus].
    Roth JA; Hölscher AH; Schneider PM
    Chirurg; 1994 Feb; 65(2):96-101. PubMed ID: 8162821
    [No Abstract]   [Full Text] [Related]  

  • 10. Short-segment Barrett's esophagus associated with high-grade dysplasia.
    Morita K; Fujimori T; Ono Y; Masuyama H; Nakamura T; Terano A
    J Gastroenterol; 2002; 37(12):1083-5. PubMed ID: 12522544
    [No Abstract]   [Full Text] [Related]  

  • 11. [Barrett's esophagus. Metaplasia-dysplasia-cancer: inexorable change?].
    Tamayo de la Cuesta JL
    Rev Gastroenterol Mex; 2003 Nov; 68 Suppl 3():40-4. PubMed ID: 15146792
    [No Abstract]   [Full Text] [Related]  

  • 12. [Heartburn--a symptom or an illness?].
    Füessl HS
    Med Klin (Munich); 2004 May; 99(5):237-49; quiz 250. PubMed ID: 15146287
    [No Abstract]   [Full Text] [Related]  

  • 13. [Expression of c-myb in reflux esophagitis, Barrett esophagus and esophageal adenocarcinoma].
    Ren CR; Dong L; Guo XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Dec; 30(12):2693-5. PubMed ID: 21177182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic reflux esophagitis with endobrachyesophagus and multifocal adenocarcinoma].
    Lange U; Peek A; Bähr R; Frenzel H
    Leber Magen Darm; 1992 May; 22(3):121-4. PubMed ID: 1625510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does short-segment columnar-lined esophagus elongate during a mean follow-up period of 5.7 years?
    Manabe N; Haruma K; Imamura H; Kamada T; Kusunoki H; Inoue K; Shiotani A; Hata J
    Dig Endosc; 2011 Apr; 23(2):166-72. PubMed ID: 21429023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting surveillance in Barrett's esophagus.
    Hillman L
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1311-2. PubMed ID: 18853989
    [No Abstract]   [Full Text] [Related]  

  • 17. Reflux esophagitis and Barrett's esophagus: the diagnostic role of esophageal mucosal biopsies.
    Arvelo G; Marcial MA
    Bol Asoc Med P R; 1989 Sep; 81(9):351-4. PubMed ID: 2684195
    [No Abstract]   [Full Text] [Related]  

  • 18. Progression of Barrett's esophagus to adenocarcinoma despite antireflux surgery.
    von Conrady D; Smith MJ; Khan MF; Tan S; Mortimer G; McAnena OJ
    Endoscopy; 2008 Sep; 40 Suppl 2():E68-9. PubMed ID: 18633915
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
    Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
    Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correspondence re: R. Kim et al., Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol., Biomark. Prev., 6: 369-377, 1997.
    Morgan G
    Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):265. PubMed ID: 9521445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.